inotuzumab ozogamicin   Click here for help

GtoPdb Ligand ID: 8266

Synonyms: Besponsa® | CMC-544
Approved drug Immunopharmacology Ligand
inotuzumab ozogamicin is an approved drug (EMA & FDA (2017))
Compound class: Antibody
Comment: Inotuzumab ozogamicin is an antibody-drug conjugate (ADC) that targets delivery of the highly cytotoxic ozogamicin (a derivative of calicheamicin γ1) to CD22 (SIGLEC-2) +ve myeloid cells [1]. The calicheamicin derivative is N-acetyl gamma calicheamicin dimethylhydrazide as reported by DiJoseph et al (2004) [1].
Click here for help
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (EMA & FDA (2017))
International Nonproprietary Names Click here for help
INN number INN
8574 inotuzumab ozogamicin
Synonyms Click here for help
Besponsa® | CMC-544
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 259
Other databases
GtoPdb PubChem SID 252166478
Search PubMed clinical trials inotuzumab ozogamicin
Search PubMed titles inotuzumab ozogamicin
Search PubMed titles/abstracts inotuzumab ozogamicin
Wikipedia Inotuzumab ozogamicin